PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933333
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933333
The global ambulatory arrhythmia monitoring devices market is experiencing substantial growth, driven by a rising prevalence of cardiovascular disorders, increasing geriatric population, and technological advancements in cardiac monitoring. These devices are primarily used to monitor abnormal heart rhythms over extended periods in settings such as hospitals, ambulatory surgical centers (ASCs), clinics, and home care environments. Conditions such as atrial fibrillation, tachycardia, bradycardia, and ventricular fibrillation are fostering demand for effective diagnostic and monitoring solutions worldwide.
In 2025, the market was valued at USD 6.6 billion and is projected to grow to USD 7.03 billion in 2026 and reach USD 12.28 billion by 2034, registering a CAGR of 7.21% during 2026-2034. North America dominated the market in 2025 with a 46.58% share, attributed to government initiatives, favorable reimbursement policies, and the launch of advanced monitoring devices by key players such as Abbott, Medtronic, and Boston Scientific.
Market Drivers and Trends
Increasing Prevalence of Cardiovascular Disorders
The rising geriatric population and the increasing incidence of arrhythmia among older adults are key market drivers. For instance, approximately 5.3 million people in the U.S. suffer from atrial fibrillation, and in Germany, 1.5 million people are affected, resulting in significant healthcare expenditure. These trends are driving adoption of ambulatory monitoring devices to improve diagnostic accuracy and patient outcomes.
Technological Advancements
The shift toward wearable and smart monitoring devices is transforming the market. Devices such as Abbott's Jot Dx insertable cardiac monitor and LIVMOR Halo's FDA-approved atrial fibrillation detection system are enabling remote and real-time monitoring, which improves patient compliance and reduces clinic visits. The non-invasive nature of external monitors and the increasing preference for smart wearables are fueling market growth.
Post-COVID-19 Recovery
The market witnessed a decline during the COVID-19 pandemic due to limited clinical visits and postponed elective procedures. Revenue of major companies, including Abbott and Medtronic, dropped by approximately 10-12% in 2020. However, adoption is rebounding rapidly as healthcare services normalize and telehealth solutions complement monitoring.
Market Segmentation Analysis
By Device Type
By Type
By Application
By End-User
North America: Market size was USD 3.08 billion in 2025, with the U.S. projected to reach USD 2.81 billion in 2026, driven by awareness campaigns and strong healthcare infrastructure.
Europe: Growth is driven by a large geriatric population and advanced healthcare systems. The UK market is projected at USD 0.41 billion in 2026 and Germany at USD 0.57 billion.
Asia Pacific: Expected to register the highest CAGR, with Japan at USD 0.27 billion, China at USD 0.51 billion, and India at USD 0.25 billion in 2026, due to increasing arrhythmia prevalence and growing patient pool.
Latin America and Middle East & Africa: Anticipated moderate growth due to limited awareness and developing healthcare infrastructure.
Key Players
Major players include Abbott, Medtronic, Boston Scientific, BioTelemetry, iRhythm Technologies, Medi-Lynx Cardiac Monitoring, ZOLL Medical, and CamNtech Ltd. These companies focus on innovative devices, insertable cardiac monitors, and partnerships to expand market presence. For instance, Boston Scientific obtained pre-marketing approval for LUX-Dx insertable cardiac monitors in 2020, while iRhythm partnered with Verily to provide early warnings for asymptomatic atrial fibrillation.
Conclusion
The ambulatory arrhythmia monitoring devices market is projected to grow from USD 6.6 billion in 2025 to USD 12.28 billion by 2034, fueled by rising prevalence of cardiovascular disorders, technological innovations in remote monitoring, and expanding geriatric populations. Despite challenges such as high device costs and occasional faulty measurements, the increasing adoption of wearable smart devices, supportive reimbursement policies, and expanding healthcare infrastructure are expected to sustain growth. North America will remain dominant, while Asia Pacific is poised to emerge as the fastest-growing region.
Segmentation By Device type
By Type
By Application
By End-user
By Geography